Kestra Advisory Services
ELV icon

Kestra Advisory Services’s Elevance Health ELV Stock Holding History

Kestra Advisory Services’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.2M Buy
44,231
+35,678
+417% +$14.2M 0.05% 382
2026
Q2 		$3.31M Sell
8,553
-3,204
-27% -$1.19M 0.01% 1058
2026
Q1 		$3.44M Sell
11,757
-1,007
-8% -$331K 0.01% 991
2025
Q4 		$4.47M Buy
12,764
+1,190
+10% +$402K 0.02% 799
2025
Q3 		$3.74M Buy
11,574
+1,505
+15% +$468K 0.02% 828
2025
Q2 		$3.92M Sell
10,069
-2,807
-22% -$1.13M 0.02% 752
2025
Q1 		$5.6M Buy
12,876
+1,237
+11% +$497K 0.03% 536
2024
Q4 		$4.29M Sell
11,639
-22,575
-66% -$9.45M 0.02% 634
2024
Q3 		$17.8M Sell
34,214
-192
-0.6% -$103K 0.1% 222
2024
Q2 		$18.6M Buy
34,406
+21,493
+166% +$11.4M 0.1% 210
2024
Q1 		$6.7M Buy
12,913
+844
+7% +$420K 0.04% 428
2023
Q4 		$5.69M Buy
12,069
+104
+0.9% +$48.1K 0.05% 412
2023
Q3 		$5.21M Buy
11,965
+2,032
+20% +$922K 0.05% 372
2023
Q2 		$4.41M Sell
9,933
-1,848
-16% -$853K 0.04% 409
2023
Q1 		$5.42M Sell
11,781
-1,419
-11% -$675K 0.06% 330
2022
Q4 		$6.77M Buy
13,200
+1,931
+17% +$980K 0.06% 333
2022
Q3 		$5.12M Sell
11,269
-2,206
-16% -$1.06M 0.05% 368
2022
Q2 		$6.5M Buy
13,475
+3,534
+36% +$1.75M 0.07% 300
2022
Q1 		$4.88M Sell
9,941
-519
-5% -$237K 0.05% 376
2021
Q4 		$4.85M Sell
10,460
-8,934
-46% -$3.76M 0.05% 379
2021
Q3 		$7.23M Buy
19,394
+7,664
+65% +$2.91M 0.07% 298
2021
Q2 		$4.48M Sell
11,730
-451
-4% -$172K 0.05% 384
2021
Q1 		$4.37M Sell
12,181
-7,769
-39% -$2.5M 0.06% 363
2020
Q4 		$6.26M Buy
19,950
+19,818
+15,014% +$6.08M 0.07% 287
2020
Q3 		$2.31M Buy
+132
New +$35.5K 0.04% 392

Other funds holding ELV

Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Kestra Advisory Services's ELV Position: Q3 2026 in Review

Kestra Advisory Services increased its Elevance Health (ELV) stake by 417% in Q3 2026, buying an estimated $14.2M and bringing the position to 44,231 shares worth $17.2M. The position accounts for 0.05% of the portfolio, ranked #382.

Kestra Advisory Services first reported a position in ELV in Q3 2020 and has held it in 25 quarters since. The position peaked at $18.6M in Q2 2024. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Kestra Advisory Services held 44,231 shares of Elevance Health worth $17.2M as of Q3 2026.
  • Kestra Advisory Services bought 35,678 Elevance Health shares in Q3 2026, an estimated $14.2M.
  • Elevance Health made up 0.05% of Kestra Advisory Services's portfolio in Q3 2026, its #382 holding.
  • Kestra Advisory Services first reported a position in Elevance Health in Q3 2020 and has held it in 25 quarters since.
  • Kestra Advisory Services's Elevance Health position peaked at $18.6M in Q2 2024.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.